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coTreatment of coronary bifurcation lesions remains an ongoing challenge for interventional cardiologists. Stenting of
coronary bifurcations carries higher risk for in-stent restenosis, stent thrombosis, and recurrent clinical events. This
review summarizes the current evidence regarding application and use of biomechanical modeling in the study of stent
properties, local ﬂow dynamics, and outcomes after percutaneous coronary interventions in bifurcation lesions.
Biomechanical modeling of bifurcation stenting involves computational simulations and in vitro bench testing using
subject-speciﬁc arterial geometries obtained from in vivo imaging. Biomechanical modeling has the potential to opti-
mize stenting strategies and stent design, thereby reducing adverse outcomes. Large-scale clinical studies are needed
to establish the translation of pre-clinical ﬁndings to the clinical arena. (J Am Coll Cardiol Intv 2015;8:1281–96)
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3D = 3-dimensional
CFD = computational ﬂuid
dynamics
CT = computed tomography
ESS = endothelial shear stress
ISR = in-stent restenosis
KBI = kissing balloon inﬂation
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1282T he advent of coronary artery stentshas undoubtedly ushered a new erain interventional cardiology and
revolutionized the therapeutic management
of patients with coronary artery disease.
However, despite signiﬁcant advances,
stents are known to have several shortcom-
ings and more comprehensive insights into
the complex in vivo stent-vascular interac-
tions are required. A signiﬁcant proportionof plaques develop in coronary bifurcation regions,
and percutaneous interventions to such lesions ac-
count for one-ﬁfth of all coronary interventions (1).
Stents in bifurcations exhibit a predisposition to
higher rates of in-stent restenosis, thrombosis, and
recurrent adverse clinical events (2,3). Therefore,
the interventional management of bifurcation lesions
remains challenging and the ideal treatment strategy
is still elusive.
Locally disturbed blood ﬂow is a major determi-
nant for the development and progression of athero-
sclerosis (4–6). In particular, low endothelial shear
stress (ESS) provokes molecular, cellular, and
vascular responses in atherosclerosis-prone sites,
leading to plaque initiation and progression toward a
more “vulnerable” proﬁle via multiple mechanisms
and interactions (7,8). A detailed quantitative
appraisal of stent-induced alterations of blood ﬂow
following bifurcation stenting plays a key role in un-
derstanding this complex geometry (9). This infor-
mation can facilitate the optimization of bifurcation
stenting techniques, stent design, and subsequent
reduction of adverse outcomes.
Studies in bifurcation stenting can be classiﬁed
into computational simulations and in vitro bench
testing. Computational simulations extend from
idealized simple geometries to more complex ana-
tomical representations of animal- and patient-
speciﬁc coronary artery geometries obtained from
in vivo imaging. Computer simulations can assess the
local hemodynamic microenvironment in bifur-
cations pre- and post-stenting, providing an insighteceives honoraria from American College of Cardiology (Senior A
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intimal hyperplasia and stent thrombosis. This review
summarizes the current literature on the use of
biomechanical modeling approaches to study stent
properties, local ﬂow dynamics in stented regions,
and outcomes after percutaneous coronary in-
terventions with particular emphasis on bifurcation
stenting (Central Illustration). Animal studies corre-
lating biomechanical modeling with histopathology
ﬁndings as well as contemporary advances and chal-
lenges in patient-speciﬁc modeling for individualized
decision making are also discussed.
COMPUTATIONAL SIMULATIONS FOR
BIFURCATION STENTING OPTIMIZATION
RATIONALE AND GENERAL CHARACTERISTICS.
Computational simulations offer indispensable in-
formation into the biomechanical effects of stenting
and provide a framework for the quantitative
assessment of mechanical stresses and blood ﬂow
dynamics in the diseased vascular segment (10–13).
Mechanical simulations of stents enable virtual
investigation of different bifurcation stenting tech-
niques and can help to evaluate stenting outcomes.
Recent advances in hardware and software have
boosted the applicability and predictive accuracy of
computer simulation studies in bifurcation stenting
by diminishing the time required for geometry gen-
eration, pre-processing, numerical solution, and
post-simulation data processing. Reconstruction of
accurate geometries, realistic boundary conditions,
and constitutive laws for material properties are
essential for accurate computational studies (14).
Whereas seminal reports in this ﬁeld have employed
idealized conceptual geometrical models (15,16),
patient-speciﬁc models based on hybrid clinical cor-
onary imaging data have emerged in the recent years
(17–21). Processing of complex arterial geometries to
ﬁt a computational grid is not a trivial undertaking.
A hybrid meshing method that combines tetrahedral
and hexahedral elements has been adopted to reducessociate Editor, Clinical Trials and News, ACC.org),
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CENTRAL ILLUSTRATION Biomechanical Modeling of Coronary Artery Bifurcation Stenting
Antoniadis, A.P. et al. J Am Coll Cardiol Intv. 2015; 8(10):1281–96.
Coronary bifurcations are prone to atherosclerosis and common targets of percutaneous coronary interventions. Computational simulations
and in vitro bench testing of coronary bifurcation stenting are anticipated to enhance our understanding of the pathophysiology of stent
restenosis and thrombosis and facilitate the optimization of stenting techniques and stent design.
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1284computational time when unstructured meshes are
employed (22). In general, unstructured meshes are
more widely used as they are easier to apply, but
structured meshes may accelerate numerical solution
and yield more precise results (23). The presence and
composition of plaque critically determine the me-
chanical behavior of the arterial wall and thus the
computational simulation results. Plaques exhibit a
large variation in their mechanical properties and this
is reﬂected in the constitutive laws used in plaque
modeling (24,25). Simpliﬁed models are commonly
used to study complex and dynamic structural
vascular phenomena and interactions (26–28). The
mechanical properties of stents and balloons extrac-
ted from medical imaging or from manufacturer
speciﬁcations can also be integrated into the compu-
tational models.
COMPUTATIONAL STENT SIMULATIONS FOR STENT
DESIGN. Virtual computer testing is an invaluable
resource for the early phase design of dedicated
bifurcation stent systems. Stent architectures can be
evaluated in a virtual manner, thereby signiﬁcantly
reducing time and manufacturing costs. The proof-of-
concept and feasibility of this rationale has been
demonstrated in computer simulations of prospective
novel stents design, which successfully quantiﬁed the
effects of stent conﬁguration and procedural param-
eters in stenting outcomes (29).
Moreover, in the current drug-eluting stent era, a
sophisticated and proactive understanding of how
drug elution occurs in space and time and how much
antiproliferative compound can be eluted from the
implanted device has become a fundamental issue
affecting clinical outcomes. Computer simulations
provide important insights in the drug delivery pat-
terns for different stent types and stenting tech-
niques in coronary bifurcations (30,31). As blood
circulates around struts, ﬂow streamlines change
orientation and acquire secondary components in the
radial direction, which affects the transport of mole-
cules to the arterial layers (32). Optimal drug delivery
from stent scaffolds is a prerequisite for achieving
therapeutic drug concentrations in the wall and at the
same time abolishing the occurrence of adverse drug-
related side effects. Local pharmacodynamic and
pharmacokinetic properties of eluted compounds
in association with tissue retention proﬁles collec-
tively inﬂuence the efﬁcacy of drug-eluting stents
(33). Comparative computational analyses combining
virtual stent implantation, computational ﬂuid dy-
namics (CFD), and drug release kinetics have reported
differences in drug delivery to the main vessel and
side branch between different stenting techniques(Figure 1) (31,34). This approach yielded useful infor-
mation, which may be clinically relevant in eval-
uating the effectiveness of side branch lesion
treatment and the inﬂuence of incomplete strut
apposition and stent overlap on drug delivery.
Although computer simulations may yield high
promise in expanding our understanding of bifurca-
tion stenting techniques, certain developmental steps
are required to fully unleash its potential in the
clinical settings. To date, no clear advantage of de-
dicated bifurcation stents over conventional stents
can be demonstrated on the basis of computer simu-
lations, in vitro bench testing, animal models, and
patient-speciﬁc modeling. However, performing a
simulated bifurcation stenting procedure within
a patient-speciﬁc model is feasible and attractive.
Such computational simulations have been validated
against in vitro bench testing and have shown good
agreement (35). This approach needs to be further
validated using post-interventional in vivo imaging
modalities in patients. The automatic and stream-
lined simulation process in conjunction with recent
hardware and software advances is expected to make
feasible the study of larger volumes of data in a time-
efﬁcient manner.
COMPUTATIONAL STENT SIMULATIONS FOR THE
OPTIMIZATION OF KISSING BALLOON INFLATION.
Structural simulations have been particularly useful
in assessing the outcomes of kissing balloon inﬂation
(KBI) after bifurcation stenting strategies. Previous
studies have demonstrated that KBI may cause an
elliptic deformation and coating damage of the
proximal segment, altered strut conﬁguration,
possible arterial injury at the side branch ostium, and
high wall stresses that may lead to arterial injury
(36,37). Therefore, a minimal balloon overlap was
suggested, which would diminish the elliptic defor-
mation after KBI (38). In addition, a short non-
compliant balloon in the proximal segment may
correct local stent deformation (39). A recent study in
54 computer-simulated stent deployments compared
the standard ﬁnal KBI with a modiﬁed approach
where the side branch balloon was inﬂated ﬁrst and
then both balloons were inﬂated simultaneously with
unequal pressures. This study demonstrated that the
modiﬁed technique for ﬁnal KBI reduces the elliptical
stent deformation in the proximal main vessel and
optimizes the side branch access (40). Another study
compared KBI against dilation of the main vessel only
post single-stent deployment in arterial bifurcations.
Both approaches restored an optimal spatial stent
conﬁguration in the main vessel and similar side
branch access. KBI resulted in higher stresses in the
FIGURE 1 Computer Simulations of Bifurcation Stenting
Computational analysis of provisional side branch stenting, conventional culotte, and Tryton-based culotte. (A) Virtual stent implantation,
(B) endothelial shear stress (ESS) calculation, (C) drug release analysis. Low ESS regions are denoted in red. The drug distribution in the
arterial wall of the coronary bifurcation was evaluated at 4 time points (1 h, 6 h, 24 h, 48 h) for each stenting technique. Reprinted with
permission from Morlacchi et al. (31). Pa ¼ Pascal.
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1285arterial wall during balloon inﬂation, making it less
favorable in a single-stent strategy (28).
Computer structural simulations were also used to
investigate the biomechanical inﬂuence of the ﬁnalKBI in provisional side branch stenting. Stresses
generated in the arterial wall by stent expansion and
hemodynamic forces on the intimal layer of the vessel
were examined before and after KBI. KBI resulted in
Antoniadis et al. J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 8 , N O . 1 0 , 2 0 1 5
Biomechanical Modeling of Bifurcation Stenting A U G U S T 2 4 , 2 0 1 5 : 1 2 8 1 – 9 6
1286almost 2.5 higher average wall stress than stent
deployment in the main vessel only. KBI was favor-
able, however, with respect to local blood ﬂow pat-
terns for the side branch. Based on these simulations,
a new tapered balloon dedicated to bifurcation le-
sions was proposed to limit the structural damage
induced to the arterial wall and to enhance the local
ESS patterns (41).
Another study investigated the local hemodynamic
effects of KBI when access is performed through
proximal or distal side of the side branch (22). The
study showed that access of the side branch through
stent cells on the distal side of the side branch led to a
smaller area exposed to low ESS compared with ac-
cess to the proximal side of the side branch. This
ﬁnding provides the theoretical foundation to the
clinical experience of accessing the distal side of the
side branch when the provisional stenting strategy is
followed by KBI.
COMPUTATIONAL MODELING OF IN-STENT RESTENOSIS
AND STENT THROMBOSIS. Blood ﬂow properties in
stented arterial segments contribute signiﬁcantly to
the clinical outcomes following stenting. It has been
shown that low ESS, ﬂow recirculation, and stagna-
tion decrease convective ﬂux in the arterial wall,
resulting in local accumulation of biologically active
compounds (42–44). In animal models, areas of low
ESS between stent struts were associated with
more pronounced neointimal hyperplasia (45,46). In
humans, in-stent low-ESS regions colocalized with
increased neointimal thickness in bare-metal stents
and low ESS was associated with neointimal thick-
ness in drug-eluting stents (47). Bifurcation lesions
more frequently develop in-stent restenosis (ISR) as a
result of geometrical complexities causing disturbed
ﬂow patterns (8). Stent placement per se further ex-
acerbates the adverse hemodynamic microenviron-
ment with strut dimensions and shape, directly
inﬂuencing the ﬂow parameters and affecting stent
outcomes (43,48). Increased stent diameter relates
to ISR (49), and this likely occurs not only by in-
ducing arterial injury but also by creating a slow-ﬂow
environment within the stent with low local ESS.
Notably, stent underexpansion also favors ISR as it
adversely affects local ESS by creating small gaps
between the struts and the arterial wall and
increasing ﬂow resistance (46). Stent overlap also
relates to poor stent outcomes, and this effect might
be due to the unfavorable hemodynamic conditions
created locally in the overlapping stent segments
(7,50).
In addition to the well-known effects of ESS on
the endothelium, the wall stresses within the wallmay also play an important role in vessel injury and
remodeling (51). The stent struts cause stress con-
centrations as well as static stresses and strain in
the vessel wall that can lead to vessel injury,
inﬂammation, and cellular proliferation (52). It is
plausible that the biomechanical stresses act in
synergy (53). An inverse relation between ESS and
neointimal hyperplasia and a linear relation be-
tween wall stress and neointimal hyperplasia were
found. Of note, a linear association between the
ratio of wall stress to ESS and neointimal hyper-
plasia was noted, suggesting that both ﬂuid and
solid mechanics inﬂuence the extent of neointimal
hyperplasia (53).
IN VITRO BENCH TESTING FOR
BIFURCATION STENTING OPTIMIZATION
RATIONALE AND GENERAL CHARACTERISTICS.
In vitro bench testing of bifurcation stenting involves
the deployment of 1 or more stents within an artiﬁcial
bifurcation model and visualization of the subse-
quent deformations of the lumen and stent. Studies
of this type have been extensively used to improve
our understanding of bifurcation stenting techniques
for many years (1,54,55). This investigational ap-
proach illustrates the realistic conﬁguration of the
complex bifurcation stenting techniques with clear
visualization using high-resolution invasive imaging
(e.g., optical coherence tomography, intravascular
ultrasound) or noninvasive imaging (e.g., charge-
coupled device camera, endoscopy, scanning elec-
tron microscopy, and micro–computed tomography
(micro-CT) (56,57). Micro-CT provides clear images
with resolutions of 10 to 20 mm to enable a detailed
inspection of stent conﬁguration, an impact of post-
dilation on stent deformations, and an evaluation of
different stenting techniques in a controlled and
reproducible environment. The images acquired are
processed to allow volume rendering, geometry
rotation, cut-plane views, and ﬂy-through anima-
tions. Unlike clinical imaging modalities, in vitro
bench testing provides a thorough assessment of
stent deformations, strut apposition, and vascular
scaffolding. Furthermore, integration with CFD pro-
vides insights into the ﬂow disturbances that may
account for the higher rates of restenosis and
thrombosis in coronary bifurcations.
In recent years, considerable progress has been
achieved in construction of anatomically accurate
in vitro bifurcation models. The initial rigid poly-
methyl methacrylate phantoms were replaced by
ﬂexible silicone models. Also, the conventional
planar bifurcation models were gradually surrogated
FIGURE 2 In Vitro Bench Testing of Bifurcation Stenting
This ﬁgure highlights the importance of crossing the side branch through a distal cell of the main vessel stent to achieve good side branch
ostial opening after ﬁnal kissing balloon inﬂation (KBI). Crossing the guidewire through a distal stent cell (A) optimizes the side branch
ostial area (B), whereas crossing through a proximal stent cell (C) leaves malapposed struts near the carina (D). Adapted with permission
from Foin et al. (65).
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1287by 3-dimensional (3D)-structured geometries created
by rapid prototyping technology. These 3D models
resemble the true arterial shape and take into account
the physiologic tapering in arterial dimensions from
proximal to distal locations, thereby representing
more closely the real vascular conﬁguration (58).
IN VITRO BENCH TESTING FOR THE OPTIMIZATION
OF SIDE BRANCH RECROSSING, CRUSH, AND
CULOTTE STENTING. The characteristics of blood
ﬂow in the left main bifurcation were assessed in a
3D silicone model adopted from a patient-speciﬁc
artery featuring similar elasticity and compliance.
Flow delay was noted at the lateral wall area
(which was more prominent in the distal post-
stenotic segment) and high ﬂow at the ﬂow-
divider region. Mini-crush stenting restored ﬂow
patterns at the lateral walls but created new ﬂow
disturbance at the carina in the area lacking strut
coverage and in the overdilated area close to the
main vessel ostium (59). Interestingly, it has been
reported that when the diseased side branch ispatent in a bifurcation lesion, the magnitude of ISR
in the main vessel is higher than when the side
branch is occluded (60). This observation may
be explained by the adverse local hemodynamics
that the side branch ﬂow introduces and can
conceptually account for the nonapparent clinical
beneﬁt after double stenting of bifurcation lesions
(61,62).
The optimal side branch ostial dilation through the
main vessel stent is critical to the overall stenting
results in bifurcation regions (63,64). In vitro testing
showed that the location of wire crossing in the main
vessel stent largely affects the outcomes of side
branch ostial dilation (64), and the current recom-
mendation is to recross through a distal cell of the
main vessel stent (39). Crossing through a proximal
cell results in unapposed struts in front of the carina,
reduction of the struts-free side branch ostial area,
and suboptimal scaffolding of the side branch ostium
(Figure 2) (56,58,65). The use of optical coherence
tomography to conﬁrm the site of wire recrossing
signiﬁcantly reduces the rate of strut malapposition
FIGURE 3 In Vitro Bench Testing of Bifurcation Stenting
Continued on the next page
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1288in these settings (66). However, in the case of crush
stenting, in vitro bench testing suggests that distal
cell recrossing should not be pursued as it induces
gaps in stent scaffolding of the side branch. These
gaps are the result of the guidewire following a short
course outside the side branch stent mesh before
entering the side branch stent area (58).
In vitro bench testing yielded important infor-
mation for the optimization of culotte stenting.
Culotte stenting is more appropriate in stents with
an open-cell-based architecture. In stent cells that
cannot be sufﬁciently enlarged, the use of a
balloon that exceeds the maximum stent diameter
leads to “napkin ring” stent deformation (i.e.,
restriction of stent expansion at the side branch
ostium) (57).
IN VITRO BENCH TESTING FOR THE OPTIMIZATION
OF KBI. In vitro models have been successfully used
to assess the best strategy for post-stenting KBI in
bifurcation regions. In a 3D left main bifurcation
model, differences in stent morphology were found
between long-overlapping and minimal-overlapping
KBI followed by proximal optimization (Figure 3)
(67). The differences were variable but speciﬁc for
each stent type. Another bench study demonstrated
that a 2-step KBI after crush stenting (i.e., where
a high pressure post-dilation in the side branch is
followed by simultaneous KBI) signiﬁcantly reduced
the residual ostial stenosis compared with using sin-
gle KBI (58). Bifurcation in vitro stent models are
particularly useful in the assessment and prevention
of strut malapposition after KBI (68–70). During KBI,
the aggregate diameter of the 2 overlapping balloons
can exceed the main vessel reference diameter and
elicit an asymmetric stent expansion that can lead to
arterial overstretch and stent distortion in the prox-
imal main vessel (68,69). In vitro bench studies also
showed that sequential dilation of the side branch
and main vessel may be a possible alternative to KBI
(Figure 4) (54,69).
LIMITATIONS AND CHALLENGES OF IN VITRO
BENCH TESTING. In vitro bench testing has the
advantage of providing a realistic assessment of the
bifurcation geometry and stent properties and can be
applied in large-scale studies (58). However, there
are several shortcomings that necessitate further
consideration: 1) differences in elasticity between
in vitro vascular models and human coronary ar-
teries; 2) difﬁculty in the generation of an accurate
atherosclerotic coronary model with variable luminal
stenosis, plaque burden, and wall calciﬁcation;
3) incomplete representation of the complex 3D
Micro-computed tomography (micro-CT) study of the differences between long-
overlapping kissing balloon inﬂation (KBI) and minimal-overlapping KBI after implantation
of 4 new-generation drug-eluting stents (Resolute Integrity 3.0/22 mm, Medtronic, Santa
Rosa, California; Promus Element 3.0/24 mm, Boston Scientiﬁc, Natick, Massachusetts;
Nobori 3.0/18 mm, Terumo, Tokyo, Japan; and Xience V 3.0/23 mm, Abbott Vascular,
Santa Clara, California) in an in vitro model of left main bifurcation. (A) In the long-
overlapping approach, the stent balloon and a 3.0/15 mm post-dilation balloon were
positioned at the proximal stent edge (i) and inﬂated simultaneously (ii). (B) In the
minimal-overlapping approach, both balloons were positioned just proximal to the bifur-
cation (i) and inﬂated simultaneously (ii). The proximal main vessel was optimized with a
4.0/10 mm balloon (iii). Reprinted with permission from Murasato et al. (67). (C) Resolute
Integrity: Long-overlapping KBI led to less strut dilation at the proximal main vessel
compared with Promus Element and Nobori (arrows). Promus Element: Long-overlapping
KBI led to longitudinal stent strut deformation (arrows). Nobori: Long-overlapping KBI led
to oval-shaped dilation of the main vessel stent at the bifurcation region (arrow). Xience V:
Long-overlapping KBI maintained the 3-link structure of the stent at the proximal main
vessel (arrows) and induced inadequate strut expansion at the ostium of the side branch
(asterisk). Cross-sectional views demonstrate more oval-shaped dilation of the main
vessel stent at the bifurcation with long-overlapping KBI compared with minimal-
overlapping KBI in each stent type (courtesy of Dr. Murasato).
FIGURE 3 Continued
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1289structure of coronary bifurcations; and 4) insufﬁ-
cient representation of the effects of coronary artery
motion and deformations during the cardiac cycle on
bifurcation models, which precludes the inves-
tigation of the temporal strut deformations with
increasing inﬂation pressure. Furthermore, a widespread
application of micro-CT imaging has signiﬁcant ﬁnan-
cial and time-related constraints.
The development of more advanced, patient-
speciﬁc modeling approaches aims to address these
limitations. Three-dimensional printing can produce
accurate models of the coronary vasculature in-
cluding bifurcations of any shape using materials that
have similar properties to the arterial wall (71).
Investigation of stent types, stenting techniques, and
outcomes in these realistic geometries are anticipated
to shed further light on optimal approaches for
bifurcation stenting.
BRIDGING THE GAP BETWEEN MODELS AND
HISTOLOGY: ANIMAL STUDIES
Animal studies provide a unique opportunity to
explore the association of stent modeling data with
real tissue pathology as examined by histological
methods. Speciﬁcally, porcine animal models were
used to investigate the association between locally
disturbed ﬂow and neointimal hyperplasia after
stenting. Studies demonstrated that the localiza-
tion of in-stent neointimal hyperplasia follows the
pattern of boundary layer separation seen in in vitro
models (i.e., the lesions form immediately distal to
the ostium of the side branch and are highly eccen-
tric, with a maximum thickness at the lateral wall
of the main vessel). Histopathology assessment re-
vealed 2 distinct cellular regions within the stent:
1) an inner annular region (200 to 300 mm) populated
by dense smooth muscle cells; and 2) an outer cres-
centic region that is more prominent at the lateral
wall, rich in ﬁbrin, and exhibiting neovascularization
(Figure 5) (60).
A study in swine coronary arteries evaluated the
use of micro-CT imaging in the assessment of the
morphology and conﬁguration of a dedicated bifur-
cation stenting system (72). The proximal diameter
and area of the stents were higher than the respective
values for the distal stent edge and not very different
than the manufacturer’s values. The stent length was
shorter than the length provided by the manufacturer
in the majority of cases. This study highlighted the
use of micro-CT imaging for accurate visualization of
stent morphology and 3D conﬁguration in bi-
furcations regions and may have important implica-
tions in stent design.PATIENT-SPECIFIC COMPUTER MODELING OF
BIFURCATION STENTING
There is no doubt that both blood ﬂow and solid
mechanics of the coronary arterial wall strongly rely
on vascular geometry. For this reason, an accurate
reconstruction of the patient-speciﬁc 3D geometry for
percutaneous coronary intervention is warranted.
In vivo coronary imaging is a particularly challenging
endeavor since small arterial caliber, 3D spatial
tortuosity, and cardiac motion create practical chal-
lenges. Although coronary angiography has tra-
ditionally been the most widely used method for
coronary imaging, other methods have emerged, such
as intravascular ultrasound, optical coherence to-
mography, coronary computed tomography angiog-
raphy, and magnetic resonance imaging. Novel
imaging modalities, in particular optical coherence
tomography, offer high-resolution imaging of the
coronary lumen and assessment of the composition of
the superﬁcial plaque components, thereby serving as
the basis for more realistic CFD models and insightful
experimental investigations (73).
The various invasive and noninvasive methods are
complementary and collectively provide additional
information with regard to lumen shape, 3D anatomy,
plaque dimensions and composition, as well as stent
dimensions and strut position. Various combinations
of the preceding methods (hybrid imaging) are able
to produce highly accurate 3D reconstructions of
the coronary arteries to enable more realistic CFD
analyses, structural mechanical simulations, and
FIGURE 4 In Vitro Bench Testing of Bifurcation Stenting
Bench model testing to facilitate optimization of bifurcation stenting. (A) Deployment of a stent in the main vessel of the bifurcation model and
incomplete stent apposition proximal and at the sidebranchostium. (B)Dilation of the sidebranchwith a2.5-mmnoncompliant balloonproduces a
risk ofmalapposition opposite to the ostiumof the side branch (asterisk). (C)Kissingballoon inﬂationwith a 3.0-mmballoon in themain vessel and
a 2.5-mm balloon in the side branch simultaneously inﬂated at 10 atm. (D) Two-step sequential post-dilation of main vessel with a 3.75-mm
noncompliant balloon after side branch dilation. Adapted with permission from Foin et al. (69).
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1290ﬂuid-structure interaction models (17,74–77). How-
ever, the simultaneous reconstruction of both the
artery and the stents in in vivo settings is still not
straightforward. Currently, only optical coherencetomography permits a simultaneous clear visualiza-
tion of both the arterial wall and stents in vivo and such
methods of reconstructing true bifurcation geometry
are still under development (Figure 6) (78–80).
FIGURE 5 Animal Studies of Bifurcation Stenting
Study of in-stent restenosis after bifurcation stenting in a porcine model. (A) Serial cross sections along the bifurcation showing neointimal
hyperplasia along the lateral wall (blue dots). (B) Representative cross section showing high concentration of ﬁbrin around the stent struts,
particularly on the lateral wall. (C) Smooth muscle cell a-actin immunostaining showing abundant smooth muscle cells inside along the
lumen circumference (dense brown area). (D) Verhoeff’s elastin immunostaining shows a cellular, dense region of relatively uniform thickness
(inside yellow circle) and an extracellular matrix-rich crescent region across the lateral wall. (E, F) False-colored enhancement of ﬁbrin
concentration (green) highlights the increased neointimal hyperplasia at the lateral wall (E) versus at the ﬂow divider (F). Adapted with
permission from Richter et al. (60).
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1291For the particular case of bifurcation lesions, the
3D geometry reconstruction is more efﬁciently
accomplished via coronary CT angiography (81). The
accuracy of CT-derived coronary lumen area in
comparison to intravascular ultrasound has recently
been validated in humans (82). The image segmen-
tation and cross-sectional area extraction algorithm
for reconstruction of coronary arteries proved to be
accurate enough for the determination of vessel and
lumen area, providing fundamental morphometricdata for patient-speciﬁc models to diagnose and
treat coronary artery disease. There are a number
of challenges that need to be addressed in future
CT angiography clinical studies: 1) image quality
inﬂuences the automatic segmentation and can
result in errors; 2) lesion appearance in the vascu-
lature can vary in intensity depending on plaque
constitution and can in turn affect image quality; 3)
a uniform threshold for segmentation is not
straightforward in CT images; and 4) disconnected
FIGURE 6 In Vivo Patient-Speciﬁc Modeling of Bifurcation Stenting
In vivo optical coherence tomography-based 3-dimensional (3D) reconstruction of bifurcation stenting in man. (A) Coronary angiography
demonstrates a lesion in the left anterior descending artery and ﬁrst diagonal branch bifurcation. (B, C) Implantation of a self-expanding
dedicated bifurcation stent with an abluminal biodegradable coating (Axxess, Biosensors International, Morges, Switzerland). (D, E) Optical
coherence tomography evaluation of the ﬁnal result. (F) 3D reconstruction of the stented bifurcation. (G, H) Endothelial shear stress (ESS) and
blood velocity distribution in the 3D reconstructed bifurcation showing that ESS and ﬂow velocity are higher at the carina and lower at the
lateral walls. Reprinted with permission from Antoniadis et al. (78).
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1292gaps can create unsmoothness of vessels, and auto-
matic and manual correction of gaps is needed.
The introduction of numerical simulations of
mechanical stresses and ﬂow in patient-derived
arterial geometries can signiﬁcantly contribute to
the clinical translation of the early phase experi-
mental studies. Preliminary reports show the
biomechanical inﬂuence of stents deployment in
the coronary bifurcations during and after stentingprocedures. In particular, the straightening of
the arterial wall and the inﬂuence of 2 over-
lapping stents signiﬁcantly affects the stress
ﬁelds. The presence of overlapping devices
proved to have major impact on both local struc-
tural and hemodynamic parameters (Figure 7)
(18,19).
Accurate reproduction of patient-speciﬁc coro-
nary anatomy in the complex bifurcation regions is
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1293feasible but currently requires a hybrid imaging
approach combining the fusion and combination of
multiple modalities. In terms of the translation of
pre-clinical ﬁndings in patient-oriented outcomes,
randomized clinical trials comparing stent geome-
tries and stenting techniques with respect to subse-
quent stent restenosis and thrombosis are
warranted. Such studies should include discrete
baseline and follow-up assessments. At baseline,
combined pre-intervention coronary imaging (either
noninvasive or invasive) with immediate post-
intervention imaging is required. Pre-intervention
imaging can be used for stenting simulations,
whereas post-intervention imaging can be used for
CFD and structural analysis of the stented arteries
for correlation with outcome. At follow-up, detailed
assessment of stent parameters as well as clin-
ical outcomes will identify cases of ISR and stentFIGURE 7 In Vivo Patient-Speciﬁc Modeling of Bifurcation Stenting
Three-dimensional reconstruction of a stented left anterior descending ar
angiography and cardiac computed tomography angiography. (A) Endoth
computational ﬂuid dynamics (low ESS is denoted in red). (B) Maximum
Reprinted with permission from Chiastra et al. (18) and Morlacchi et al.thrombosis leading to adverse events. Integration of
this data and analysis will enable the identiﬁcation
of local biomechanical factors that contribute to the
clinical outcomes and therefore set the stage for
improved clinical decision making by the physicians.
Although such studies demand resources and ef-
fort, the expected clinical beneﬁts may justify the
investment.
CONCLUSIONS AND FUTURE PERSPECTIVES
Modeling approaches appear to be a fundamental
component toward the consummation of techniques
and devices for coronary bifurcation interventions.
Computer simulations and in vitro bench testing have
the potential to complement the in vivo morpholog-
ical (intravascular ultrasound, optical coherence to-
mography) and functional (fractional ﬂow reserve)tery including the diagonal branches using fusion of invasive coronary
elial shear stress (ESS) distribution in the reconstructed arteries using
principal stresses within the arterial wall of the stented segment.
(19). MPa ¼ Megapascal; Pa ¼ Pascal.
PERSPECTIVES
WHAT IS KNOWN? A large proportion of athero-
sclerotic plaques develop in coronary bifurcations,
and stenting in these regions carries higher risk for in-
stent restenosis, thrombosis, and recurrent clinical
events. Computer simulations and in vitro bench
testing can yield incremental information to the
anatomical and functional assessment of bifurcation
lesions in the catheterization laboratory, thereby
guiding percutaneous therapeutic strategies.
WHAT IS NEW? Biomechanical modeling can be
particularly useful in the study of stent behavior and
stent-wall interactions, optimization of stenting
techniques, and development of new generation
stents, ultimately improving clinical outcomes.
WHAT IS NEXT? Large-scale clinical studies are
warranted to investigate the translation of biome-
chanical modeling to daily clinical practice.
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1294assessment of coronary lesions in the catheterization
laboratory. Such modeling techniques may also be
applicable to other vascular beds, such as the com-
mon carotid artery bifurcation or the aortic bifurca-
tion into common iliac arteries, both of which are
common locations of atherosclerosis. Joint efforts
across multidisciplinary teams of interventional car-
diologists, biomedical engineers, and molecular bi-
ologists are anticipated to facilitate the effective
integration of rapidly emerging novel technologies
into clinical practice. In the challenging pursuit of
percutaneous treatment of bifurcation lesions,
modeling and simulation methods provide the op-
portunity to translate biomechanical engineering
breakthroughs into quantiﬁable and patient-oriented
clinical beneﬁts.
REPRINT REQUESTS AND CORRESPONDENCE: Dr.
Yiannis S. Chatzizisis, Cardiovascular Division, Brig-
ham and Women’s Hospital, Harvard Medical School,
75 Francis Street, Boston, Massachusetts 02115.
E-mail: ychatzizisis@icloud.com.RE F E RENCE S1. Lassen JF, Holm NR, Stankovic G, et al. Percu-
taneous coronary intervention for coronary bifur-
cation disease: consensus from the ﬁrst 10 years of
the European Bifurcation Club meetings. Euro-
Intervention 2014;10:545–60.
2. Nakazawa G, Yazdani SK, Finn AV, Vorpahl M,
Kolodgie FD, Virmani R. Pathological ﬁndings at
bifurcation lesions: the impact of ﬂow distribution
on atherosclerosis and arterial healing after
stent implantation. J Am Coll Cardiol 2010;55:
1679–87.
3. Colombo A, Moses JW, Morice MC, et al. Ran-
domized study to evaluate sirolimus-eluting stents
implanted at coronary bifurcation lesions. Circu-
lation 2004;109:1244–9.
4. Richter Y, Edelman ER. Cardiology is ﬂow. Cir-
culation 2006;113:2679–82.
5. Chatzizisis YS, Coskun AU, Jonas M,
Edelman ER, Feldman CL, Stone PH. Role of
endothelial shear stress in the natural history of
coronary atherosclerosis and vascular remodeling:
molecular, cellular, and vascular behavior. J Am
Coll Cardiol 2007;49:2379–93.
6. Koskinas KC, Chatzizisis YS, Antoniadis AP,
Giannoglou GD. Role of endothelial shear stress in
stent restenosis and thrombosis: pathophysiologic
mechanisms and implications for clinical trans-
lation. J Am Coll Cardiol 2012;59:1337–49.
7. Koskinas KC, Chatzizisis YS, Baker AB,
Edelman ER, Stone PH, Feldman CL. The role
of low endothelial shear stress in the conver-
sion of atherosclerotic lesions from stable to
unstable plaque. Curr Opin Cardiol 2009;24:
580–90.8. Giannoglou GD, Antoniadis AP, Koskinas KC,
Chatzizisis YS. Flow and atherosclerosis in coro-
nary bifurcations. EuroIntervention 2010;6 Suppl
J:J16–23.
9. Antoniadis AP, Giannopoulos AA, Wentzel JJ,
et al. Impact of local ﬂow haemodynamics on
atherosclerosis in coronary artery bifurcations.
EuroIntervention 2015;11 Suppl V:V18–22.
10. Holzapfel GA, Stadler M, Gasser TC. Changes
in the mechanical environment of stenotic arteries
during interaction with stents: computational
assessment of parametric stent designs. J Biomech
Eng 2005;127:166–80.
11. Morlacchi S, Migliavacca F. Modeling stented
coronary arteries: where we are, where to go. Ann
Biomed Eng 2013;41:1428–44.
12. Duraiswamy N, Schoephoerster RT,
Moore JE Jr. Comparison of near-wall hemody-
namic parameters in stented artery models.
J Biomech Eng 2009;131:061006.
13. Foin N, Gutierrez-Chico JL, Nakatani S, et al.
Incomplete stent apposition causes high shear
ﬂow disturbances and delay in neointimal
coverage as a function of strut to wall detachment
distance: implications for the management of
incomplete stent apposition. Circ Cardiovasc
Interv 2014;7:180–9.
14. Migliavacca F, Chiastra C, Chatzizisis YS,
Dubini G. Virtual bench testing to study coronary
bifurcation stenting. EuroIntervention 2015;11
Suppl V:V31–4.
15. Martin D, Boyle FJ. Computational structural
modelling of coronary stent deployment: a review.Comput Methods Biomech Biomed Engin 2011;14:
331–48.
16. Murphy J, Boyle F. Predicting neointimal hy-
perplasia in stented arteries using time-dependent
computational ﬂuid dynamics: a review. Comput
Biol Med 2010;40:408–18.
17. Gijsen FJ, Migliavacca F, Schievano S, et al.
Simulation of stent deployment in a realistic
human coronary artery. Biomed Eng Online
2008;7:23.
18. Chiastra C, Morlacchi S, Gallo D, et al.
Computational ﬂuid dynamic simulations of
image-based stented coronary bifurcation models.
J R Soc Interface 2013;10:20130193.
19. Morlacchi S, Colleoni SG, Cardenes R, et al.
Patient-speciﬁc simulations of stenting pro-
cedures in coronary bifurcations: two clinical
cases. Med Eng Phys 2013;35:1272–81.
20. Gundert TJ, Shadden SC, Williams AR, Koo BK,
Feinstein JA, Ladisa JF Jr. A rapid and computa-
tionally inexpensive method to virtually implant
current and next-generation stents into subject-
speciﬁc computational ﬂuid dynamics models.
Ann Biomed Eng 2011;39:1423–37.
21. Ellwein LM, Otake H, Gundert TJ, et al. Optical
coherence tomography for patient-speciﬁc 3D ar-
tery reconstruction and evaluation of wall shear
stress in a left circumﬂex coronary artery. Car-
diovasc Eng Technol 2011;2:212–27.
22. Chiastra C, Morlacchi S, Pereira S, Dubini G,
Migliavacca F. Computational ﬂuid dynamics of
stented coronary bifurcations studied with a
hybrid discretization method. Eur J Mech B/Fluids
2012;35:76–84.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 8 , N O . 1 0 , 2 0 1 5 Antoniadis et al.
A U G U S T 2 4 , 2 0 1 5 : 1 2 8 1 – 9 6 Biomechanical Modeling of Bifurcation Stenting
129523. De Santis G, De Beule M, Segers P, Verdonck P,
Verhegghe B. Patient-speciﬁc computational hae-
modynamics: generation of structured and
conformal hexahedral meshes from triangulated
surfaces of vascular bifurcations. Comput Methods
Biomech Biomed Engin 2011;14:797–802.
24. Loree HM, Grodzinsky AJ, Park SY, Gibson LJ,
Lee RT. Static circumferential tangential modulus
of human atherosclerotic tissue. J Biomech 1994;
27:195–204.
25. Akyildiz AC, Speelman L, Gijsen FJ. Mechanical
properties of human atherosclerotic intima tissue.
J Biomech 2014;47:773–83.
26. Zhao S, Gu L, Froemming SR. Finite element
analysis of the implantation of a self-expanding
stent: impact of lesion calciﬁcation. J Med De-
vices 2012;6:21001.
27. Pericevic I, Lally C, Toner D, Kelly DJ. The in-
ﬂuence of plaque composition on underlying
arterial wall stress during stent expansion: the
case for lesion-speciﬁc stents. Med Eng Phys
2009;31:428–33.
28. Gastaldi D, Morlacchi S, Nichetti R, et al.
Modelling of the provisional side-branch stenting
approach for the treatment of atherosclerotic
coronary bifurcations: effects of stent positioning.
Biomech Model Mechanobiol 2010;9:551–61.
29. Mortier P. Computer Modelling of Coronary
Bifurcation Stenting. Ghent, Belgium: Ghent Uni-
versity, 2010.
30. Kolandaivelu K, Leiden BB, Edelman ER. Pre-
dicting response to endovascular therapies: dis-
secting the roles of local lesion complexity,
systemic comorbidity, and clinical uncertainty.
J Biomech 2014;47:908–21.
31. Morlacchi S, Chiastra C, Cutri E, et al. Stent
deformation, physical stress, and drug elution
obtained with provisional stenting, conventional
culotte and Tryton-based culotte to treat bi-
furcations: a virtual simulation study. Euro-
Intervention 2014;9:1441–53.
32. Duraiswamy N, Jayachandran B, Byrne J,
Moore JE Jr., Schoephoerster RT. Spatial distri-
bution of platelet deposition in stented arterial
models under physiologic ﬂow. Ann Biomed Eng
2005;33:1767–77.
33. Tzafriri AR, Vukmirovic N, Kolachalama VB,
Astaﬁeva I, Edelman ER. Lesion complexity de-
termines arterial drug distribution after local drug
delivery. J Control Release 2010;142:332–8.
34. Cutri E, Zunino P, Morlacchi S, Chiastra C,
Migliavacca F. Drug delivery patterns for different
stenting techniques in coronary bifurcations: a
comparative computational study. Biomech Model
Mechanobiol 2013;12:657–69.
35. Mortier P, De Beule M, Van Loo D,
Verhegghe B, Verdonck P. Finite element analysis
of side branch access during bifurcation stenting.
Med Eng Phys 2009;31:434–40.
36. Guerin P, Pilet P, Finet G, et al. Drug-eluting
stents in bifurcations: bench study of strut
deformation and coating lesions. Circ Cardiovasc
Interv 2010;3:120–6.
37. Basalus MW, van Houwelingen KG, Ankone MJ,
Feijen J, von Birgelen C. Micro-computed tomo-
graphic assessment following extremely oversizedpartial postdilatation of drug-eluting stents.
EuroIntervention 2010;6:141–8.
38. Murasato Y. Bench testing of coronary bifur-
cation stenting techniques: How is it done? Does it
help technical decision making? In: Moussa ID,
Colombo A, editors. Tips and Tricks in Interven-
tional Therapy of Coronary Bifurcation Lesions.
location. London, UK: Informa Healthcare, 2010:
193–210.
39. Hildick-Smith D, Lassen JF, Albiero R, et al.
Consensus from the 5th European Bifurcation Club
meeting. EuroIntervention 2010;6:34–8.
40. Mortier P, Hikichi Y, Foin N, et al. Provisional
stenting of coronary bifurcations: insights into
ﬁnal kissing balloon post-dilation and stent design
by computational modeling. J Am Coll Cardiol Intv
2014;7:325–33.
41. Morlacchi S, Chiastra C, Gastaldi D, Pennati G,
Dubini G, Migliavacca F. Sequential structural and
ﬂuid dynamic numerical simulations of a stented
bifurcated coronary artery. J Biomech Eng 2011;
133:121010.
42. Basmadjian D. The effect of ﬂow and mass
transport in thrombogenesis. Ann Biomed Eng
1990;18:685–709.
43. Kolandaivelu K, Swaminathan R, Gibson WJ,
et al. Stent thrombogenicity early in high-risk
interventional settings is driven by stent design
and deployment and protected by polymer-drug
coatings. Circulation 2011;123:1400–9.
44. Kolandaivelu K, Edelman ER. Environmental
inﬂuences on endovascular stent platelet reac-
tivity: an in vitro comparison of stainless steel and
gold surfaces. J Biomed Mater Res A 2004;70:
186–93.
45. LaDisa JF Jr., Olson LE, Molthen RC, et al.
Alterations in wall shear stress predict sites of
neointimal hyperplasia after stent implantation in
rabbit iliac arteries. Am J Physiol Heart Circ Physiol
2005;288:H2465–75.
46. Chen HY, Hermiller J, Sinha AK, Sturek M,
Zhu L, Kassab GS. Effects of stent sizing on
endothelial and vessel wall stress: potential
mechanisms for in-stent restenosis. J Appl Physiol
(1985) 2009;106:1686–91.
47. Gijsen FJ, Oortman RM, Wentzel JJ, et al.
Usefulness of shear stress pattern in predicting
neointima distribution in sirolimus-eluting stents
in coronary arteries. Am J Cardiol 2003;92:1325–8.
48. Jimenez JM, Davies PF. Hemodynamically
driven stent strut design. Ann Biomed Eng 2009;
37:1483–94.
49. Sick P, Huttl T, Niebauer J, et al. Inﬂuence of
residual stenosis after percutaneous coronary
intervention with stent implantation on develop-
ment of restenosis and stent thrombosis. Am J
Cardiol 2003;91:148–53.
50. Raber L, Juni P, Loffel L, et al. Impact of stent
overlap on angiographic and long-term clinical
outcome in patients undergoing drug-eluting
stent implantation. J Am Coll Cardiol 2010;55:
1178–88.
51. Kassab GS, Navia JA. Biomechanical consider-
ations in the design of graft: the homeostasis hy-
pothesis. Annu Rev Biomed Eng 2006;8:499–535.52. Thubrikar MJ, Baker JW, Nolan SP. Inhibition of
atherosclerosis associated with reduction of arte-
rial intramural stress in rabbits. Arteriosclerosis
1988;8:410–20.
53. Chen HY, Sinha AK, Choy JS, et al. Mis-sizing of
stent promotes intimal hyperplasia: impact of
endothelial shear and intramural stress. Am J
Physiol Heart Circ Physiol 2011;301:H2254–63.
54. Ormiston JA, Webster MW, El Jack S, et al.
Drug-eluting stents for coronary bifurcations:
bench testing of provisional side-branch strate-
gies. Catheter Cardiovasc Interv 2006;67:49–55.
55. Foin N, Mattesini A, Ghione M, et al. Tools and
techniques clinical: optimising stenting strategy in
bifurcation lesions with insights from in vitro
bifurcation models. EuroIntervention 2013;9:
885–7.
56. Murasato Y, Horiuchi M, Otsuji Y. Three-
dimensional modeling of double-stent techniques
at the left main coronary artery bifurcation using
micro-focus X-ray computed tomography. Cath-
eter Cardiovasc Interv 2007;70:211–20.
57. Murasato Y, Hikichi Y, Horiuchi M. Examination
of stent deformation and gap formation after
complex stenting of left main coronary artery bi-
furcations using microfocus computed tomogra-
phy. J Interv Cardiol 2009;22:135–44.
58. Ormiston JA, Webster MW, Webber B,
Stewart JT, Ruygrok PN, Hatrick RI. The “crush”
technique for coronary artery bifurcation stenting:
insights from micro-computed tomographic im-
aging of bench deployments. J Am Coll Cardiol
Intv 2008;1:351–7.
59. Murasato Y, Hikichi Y, Nakamura S, et al.
Recent perspective on coronary bifurcation inter-
vention: statement of the “Bifurcation Club in
KOKURA.” J Interv Cardiol 2010;23:295–304.
60. Richter Y, Groothuis A, Seifert P, Edelman ER.
Dynamic ﬂow alterations dictate leukocyte adhe-
sion and response to endovascular interventions.
J Clin Invest 2004;113:1607–14.
61. Katritsis DG, Siontis GC, Ioannidis JP. Double
versus single stenting for coronary bifurcation le-
sions: a meta-analysis. Circ Cardiovasc Interv
2009;2:409–15.
62. Zimarino M, Corazzini A, Ricci F, Di Nicola M,
De Caterina R. Late thrombosis after double versus
single drug-eluting stent in the treatment of cor-
onary bifurcations: a meta-analysis of randomized
and observational studies. J Am Coll Cardiol Intv
2013;6:687–95.
63. Mortier P, Van Loo D, De Beule M, et al.
Comparison of drug-eluting stent cell size using
micro-CT: important data for bifurcation stent
selection. EuroIntervention 2008;4:391–6.
64. Ormiston JA, Webster MW, Ruygrok PN,
Stewart JT, White HD, Scott DS. Stent deformation
following simulated side-branch dilatation: a
comparison of ﬁve stent designs. Catheter Car-
diovasc Interv 1999;47:258–64.
65. Foin N, Torii R, Alegria E, et al. Location of side
branch access critically affects results in bifurca-
tion stenting: insights from bench modeling and
computational ﬂow simulation. Int J Cardiol 2013;
168:3623–8.
Antoniadis et al. J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 8 , N O . 1 0 , 2 0 1 5
Biomechanical Modeling of Bifurcation Stenting A U G U S T 2 4 , 2 0 1 5 : 1 2 8 1 – 9 6
129666. Alegra-Barrero E, Foin N, Chan PH, et al. Op-
tical coherence tomography for guidance of distal
cell recrossing in bifurcation stenting: choosing
the right cell matters. EuroIntervention 2012;8:
205–13.
67. Murasato Y, Iwasaki K, Yamamoto T, et al.
Optimal kissing balloon inﬂation after single-stent
deployment in a coronary bifurcation model.
EuroIntervention 2014;10:934–41.
68. Foin N, Secco GG, Ghilencea L, Krams R, Di
Mario C. Final proximal post-dilatation is neces-
sary after kissing balloon in bifurcation stenting.
EuroIntervention 2011;7:597–604.
69. Foin N, Torii R, Mortier P, et al. Kissing balloon
or sequential dilation of the side branch and main
vessel for provisional stenting of bifurcations:
lessons from micro-computed tomography and
computational simulations. J Am Coll Cardiol Intv
2012;5:47–56.
70. Foin N, Alegria-Barrero E, Torii R, et al. Crush,
culotte, T and protrusion: which 2-stent technique
for treatment of true bifurcation lesions? insights
from in vitro experiments and micro-computed
tomography. Circ J 2013;77:73–80.
71. Mitsouras D, Liacouras P, Imanzadeh A, et al.
Medical 3D printing for the radiologist. Radio-
Graphics 2015. In press.72. Kralev S, Haag B, Spannenberger J, et al.
Expansion of the Multi-Link Frontier coronary
bifurcation stent: micro-computed tomographic
assessment in human autopsy and porcine heart
samples. PLoS One 2011;6:e21778.
73. Toutouzas K, Chatzizisis YS, Riga M, et al.
Accurate and reproducible reconstruction of
coronary arteries and endothelial shear stress
calculation using 3D OCT: comparative study to 3D
IVUS and3DQCA. Atherosclerosis 2015;240:510–9.
74. Cardenes R, Diez JL, Larrabide I, Bogunovic H,
Frangi AF. 3D modeling of coronary artery bi-
furcations from CTA and conventional coronary
angiography. Med Image Comput Comput Assist
Interv 2011;14:395–402.
75. GiannoglouGD, Chatzizisis YS, Sianos G, et al. In-
vivovalidation of spatially correct three-dimensional
reconstruction of human coronary arteries by inte-
grating intravascular ultrasound and biplane angi-
ography. Coron Artery Dis 2006;17:533–43.
76. Tu S, Holm NR, Koning G, Huang Z, Reiber JH.
Fusion of 3D QCA and IVUS/OCT. Int J Cardiovasc
Imaging 2011;27:197–207.
77. Mortier P, Wentzel JJ, De Santis G, et al. Pa-
tient-speciﬁc computer modelling of coronary
bifurcation stenting: the John Doe programme.
EuroIntervention 2015;11 Suppl V:V35–9.78. Antoniadis AP, Jaguszewski M, Maier W,
Giannoglou GD, Luscher TF, Templin C. Geometri-
cally correct three-dimensional optical coherence
tomography: ﬁrst self-expanding bifurcation stent
evaluation. Eur Heart J 2013;34:2715.
79. Tu S, Pyxaras SA, Li Y, Barbato E, Reiber JH,
Wijns W. In vivo ﬂow simulation at coronary bifur-
cation reconstructed by fusion of 3-dimensional
X-ray angiography and optical coherence tomog-
raphy. Circ Cardiovasc Interv 2013;6:e15–7.
80. Karanasos A, Li Y, Tu S, et al. Is it safe to
implant bioresorbable scaffolds in ostial side-
branch lesions? Impact of ’neo-carina’ formation
on main-branch ﬂow pattern. Longitudinal clinical
observations. Atherosclerosis 2015;238:22–5.
81. Ramkumar PG, Mitsouras D, Feldman CL,
Stone PH, Rybicki FJ. New advances in cardiac
computed tomography. Curr Opin Cardiol 2009;
24:596–603.
82. Luo T, Wischgoll T. Kwon Koo B, Huo Y, Kas-
sab GS. IVUS validation of patient coronary artery
lumen area obtained from CT images. PLoS One
2014;9:e86949.
KEY WORDS bifurcation, biomechanical
stress, coronary artery disease, endothelial
shear stress, stent(s)
